IL96260A - Pharmaceutical preparations containing derivatives and analogues of pyrimidone for the short-term treatment of skin diseases and infections - Google Patents

Pharmaceutical preparations containing derivatives and analogues of pyrimidone for the short-term treatment of skin diseases and infections

Info

Publication number
IL96260A
IL96260A IL9626090A IL9626090A IL96260A IL 96260 A IL96260 A IL 96260A IL 9626090 A IL9626090 A IL 9626090A IL 9626090 A IL9626090 A IL 9626090A IL 96260 A IL96260 A IL 96260A
Authority
IL
Israel
Prior art keywords
treatment
asthma
pharmaceutical composition
bicyclo
hept
Prior art date
Application number
IL9626090A
Other languages
English (en)
Hebrew (he)
Other versions
IL96260A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL96260A0 publication Critical patent/IL96260A0/xx
Publication of IL96260A publication Critical patent/IL96260A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9626090A 1989-11-13 1990-11-06 Pharmaceutical preparations containing derivatives and analogues of pyrimidone for the short-term treatment of skin diseases and infections IL96260A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005221 WO1991007177A1 (en) 1989-11-13 1989-11-13 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders

Publications (2)

Publication Number Publication Date
IL96260A0 IL96260A0 (en) 1991-08-16
IL96260A true IL96260A (en) 1995-11-27

Family

ID=22215372

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9626090A IL96260A (en) 1989-11-13 1990-11-06 Pharmaceutical preparations containing derivatives and analogues of pyrimidone for the short-term treatment of skin diseases and infections

Country Status (17)

Country Link
US (1) US5342842A (de)
EP (1) EP0428313B1 (de)
JP (2) JPH0662412B2 (de)
KR (1) KR930001832B1 (de)
AT (1) ATE101040T1 (de)
AU (1) AU627631B2 (de)
CA (1) CA2029704C (de)
DE (1) DE69006452T2 (de)
DK (1) DK0428313T3 (de)
HU (1) HU212311B (de)
IE (1) IE63472B1 (de)
IL (1) IL96260A (de)
MY (1) MY111474A (de)
NZ (1) NZ236038A (de)
PT (1) PT95854B (de)
WO (2) WO1991007177A1 (de)
ZA (1) ZA909043B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
CA2150812C (en) * 1992-12-02 2002-12-24 Allen J. Duplantier Catechol diethers as selective pde iv inhibitors
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
ES2139754T3 (es) * 1993-11-26 2000-02-16 Pfizer 3-fenil-2-isoxazolinas como agentes antiinflamatorios.
WO1995024192A1 (en) * 1994-03-09 1995-09-14 Pfizer Inc. Isoxazoline compounds as 5-lipoxygenase inhibitors
CA2185019C (en) * 1994-03-09 2000-08-08 Pfizer Limited Isoxazoline compounds as inhibitors of tnf release
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
JP4373497B2 (ja) 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用
CA2264685C (en) 1996-08-27 2002-10-15 Kyoji Noda 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
EP2258689A1 (de) * 2000-03-16 2010-12-08 Biolipox AB Benzylierte PDE4-Inhibitoren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8416140D0 (en) * 1984-06-25 1984-08-01 Fujisawa Pharmaceutical Co Pyrimidinone derivatives
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant

Also Published As

Publication number Publication date
IE904058A1 (en) 1991-05-22
EP0428313B1 (de) 1994-02-02
AU6653690A (en) 1991-08-01
JP2514163B2 (ja) 1996-07-10
HU9201575D0 (en) 1993-04-28
DE69006452D1 (de) 1994-03-17
PT95854A (pt) 1991-09-13
IE63472B1 (en) 1995-04-19
AU627631B2 (en) 1992-08-27
WO1991007178A1 (en) 1991-05-30
PT95854B (pt) 1997-11-28
WO1991007177A1 (en) 1991-05-30
DK0428313T3 (da) 1994-03-07
HUT70052A (en) 1995-09-28
EP0428313A2 (de) 1991-05-22
CA2029704A1 (en) 1991-05-14
JPH0748255A (ja) 1995-02-21
HU212311B (en) 1996-05-28
MY111474A (en) 2000-06-30
US5342842A (en) 1994-08-30
JPH03209322A (ja) 1991-09-12
IL96260A0 (en) 1991-08-16
EP0428313A3 (en) 1991-11-06
JPH0662412B2 (ja) 1994-08-17
NZ236038A (en) 1997-03-24
KR910009259A (ko) 1991-06-28
KR930001832B1 (ko) 1993-03-15
CA2029704C (en) 1995-02-07
DE69006452T2 (de) 1994-05-11
ATE101040T1 (de) 1994-02-15
ZA909043B (en) 1992-06-24

Similar Documents

Publication Publication Date Title
EP0428302B1 (de) Enzymatische Auflösung von Endo-bicyclo(2.2.1)-heptan-2-ol und pharmazeutische Derivate
US6869956B2 (en) Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
US5342842A (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
IE54423B1 (en) Combination of 2-substituted penems with dipeptidase inhibitors
EP1363993A2 (de) Verfahren zur behandlung von entzündungs- und immunkrankheiten unter verwendung der i kappa b-kinase (ikk)
AU2002247059A1 (en) Method of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK)
JP3808921B2 (ja) 細胞接着阻害剤
JPS61246183A (ja) 置換１，８‐ナフチリジノン類、それらの製造方法およびそれらを含む医薬組成物
US5270206A (en) Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
US5461056A (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
CA2048959C (en) 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
JPH06505698A (ja) 新規化合物
US4880793A (en) Combination of thienamycin-type antibiotics with dipeptidase inhibitors
JPH0678230B2 (ja) 好中球によるエラスターゼの遊離の阻害剤としてのテニダップ
JPH07196509A (ja) イソキノリン誘導体を含有する医薬組成物
US5395935A (en) Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
JPS632964A (ja) 腎臓ジペプチダ−ゼ阻害剤としてのビス（シクロプロパンカルボキサミド）アルカジエンジオン酸
JPH09301868A (ja) 抗白内障剤
JPH04503509A (ja) ピリミド―ピリミジンリポキシゲナーゼ阻害化合物
EP0497609A1 (de) Pyrimido-benzothiazinderivate zur Behandlung von Entzündung, Allergie and kardiovaskulären Erkrankung

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed